Literature DB >> 28753856

Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.

Haider Rahbar1, Patrick Karabon1, Mani Menon1, Quoc-Dien Trinh2, Firas Abdollah3.   

Abstract

In 2012, the US Preventive Services Task Force recommended against prostate-specific antigen (PSA) screening. Following the initial decrease in PSA screening rate, there appears to be no further decrease in screening rate from 2013 to 2015. In addition, the screening rate did not differ by age or race.
Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28753856     DOI： 10.1016/j.euf.2017.02.004

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN： 2405-4569


  3 in total

1.  Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations.

Authors:  Isaac E Kim; Daniel D Kim; Sinae Kim; Shuangge Ma; Thomas L Jang; Eric A Singer; Saum Ghodoussipour; Isaac Yi Kim
Journal:  BMC Urol       Date:  2022-06-25       Impact factor: 2.090

2.  Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening.

Authors:  Ahmed S Zakaria; Alice Dragomir; Fadi Brimo; Wassim Kassouf; Simon Tanguay; Armen Aprikian
Journal:  BMC Urol       Date:  2018-08-20       Impact factor: 2.264

3.  Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.

Authors:  Kevin H Kensler; Claire H Pernar; Brandon A Mahal; Paul L Nguyen; Quoc-Dien Trinh; Adam S Kibel; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.